Xini Cong

30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade

D. Serie, K. Lindpaintner, Gege Xu, 2021, Journal for ImmunoTherapy of Cancer.

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy

Lisa M. Ebert, D. Serie, Dennie T. Frederick, 2023, Frontiers in Immunology.

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19

D. Serie, S. Reddy, P. Ramachandran, 2022, medRxiv.